Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 367 entries
Sorted by: Best Match Show Resources per page
The acquisition of problem solving competence: evidence from 41 countries that math and science education matters

discipline specific-education (e.g., chemistry education, biology education, economics education)

Scherer R, Beckmann JF.
GSID: xGYMYjQrO2kJ
R Scherer, JF Beckmann - … in Education, 2014 - largescaleassessmentsineducation …

… math and science require skills beyond problem solving (eg, the application of domain-specific … A positive CUUI indicates that the subject-specific education (ie, math or science) in a country … organization in the context of its socio-economic capabilities....

Cite
Scherer, R., & Beckmann, J. F. (2014). The acquisition of problem solving competence: evidence from 41 countries that math and science education matters. Large-scale Assessments in Education, 2(1), 1-22.
Scherer, Ronny, and Jens F. Beckmann. "The acquisition of problem solving competence: evidence from 41 countries that math and science education matters." Large-scale Assessments in Education 2.1 (2014): 1-22.
Copy Download .nbib Format: MLA
14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts.

Breast care (Basel, Switzerland)

Jackisch C, Harbeck N, Huober J, von Minckwitz G, Gerber B, Kreipe HH, Liedtke C, Marschner N, Möbus V, Scheithauer H, Schneeweiss A, Thomssen C, Loibl S, Beckmann MW, Blohmer JU, Costa SD, Decker T, Diel I, Fasching PA, Fehm T, Janni W, Lück HJ, Maass N, Scharl A, Untch M.
PMID: 26557827
Breast Care (Basel). 2015 Jul;10(3):211-9. doi: 10.1159/000433590. Epub 2015 Jun 23.

The key topics of this year's 14th St. Gallen Consensus Conference on the diagnosis and therapy of primary breast cancer were again questions about breast surgery and axillary surgery, radio-oncology and systemic therapy options in consideration of tumor biology,...

Cite
Jackisch C, Harbeck N, Huober J, et al. 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts. Breast Care (Basel). 2015;10(3):211-9doi: 10.1159/000433590.
Jackisch, C., Harbeck, N., Huober, J., von Minckwitz, G., Gerber, B., Kreipe, H. H., Liedtke, C., Marschner, N., Möbus, V., Scheithauer, H., Schneeweiss, A., Thomssen, C., Loibl, S., Beckmann, M. W., Blohmer, J. U., Costa, S. D., Decker, T., Diel, I., Fasching, P. A., Fehm, T., Janni, W., Lück, H. J., Maass, N., Scharl, A., & Untch, M. (2015). 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts. Breast care (Basel, Switzerland), 10(3), 211-9. https://doi.org/10.1159/000433590
Jackisch, Christian, et al. "14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts." Breast care (Basel, Switzerland) vol. 10,3 (2015): 211-9. doi: https://doi.org/10.1159/000433590
Jackisch C, Harbeck N, Huober J, von Minckwitz G, Gerber B, Kreipe HH, Liedtke C, Marschner N, Möbus V, Scheithauer H, Schneeweiss A, Thomssen C, Loibl S, Beckmann MW, Blohmer JU, Costa SD, Decker T, Diel I, Fasching PA, Fehm T, Janni W, Lück HJ, Maass N, Scharl A, Untch M. 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts. Breast Care (Basel). 2015 Jul;10(3):211-9. doi: 10.1159/000433590. Epub 2015 Jun 23. PMID: 26557827; PMCID: PMC4569213.
Copy Download .nbib Format: NLM
Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?.

Geburtshilfe und Frauenheilkunde

Findeklee S, Lotz L, Heusinger K, Hoffmann I, Dittrich R, Beckmann MW.
PMID: 26726265
Geburtshilfe Frauenheilkd. 2015 Dec;75(12):1243-1249. doi: 10.1055/s-0035-1558184.

Protecting the fertility of patients with oncologic disease is becoming more and more important, as fulfilling the wish to have children is increasingly occurring at a later stage in life and long-term survival rates after cancer are continuing to...

Cite
Findeklee S, Lotz L, Heusinger K, et al. Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?. Geburtshilfe Frauenheilkd. 2015;75(12):1243-1249doi: 10.1055/s-0035-1558184.
Findeklee, S., Lotz, L., Heusinger, K., Hoffmann, I., Dittrich, R., & Beckmann, M. W. (2015). Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?. Geburtshilfe und Frauenheilkunde, 75(12), 1243-1249. https://doi.org/10.1055/s-0035-1558184
Findeklee, S, et al. "Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?." Geburtshilfe und Frauenheilkunde vol. 75,12 (2015): 1243-1249. doi: https://doi.org/10.1055/s-0035-1558184
Findeklee S, Lotz L, Heusinger K, Hoffmann I, Dittrich R, Beckmann MW. Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?. Geburtshilfe Frauenheilkd. 2015 Dec;75(12):1243-1249. doi: 10.1055/s-0035-1558184. PMID: 26726265; PMCID: PMC4686370.
Copy Download .nbib Format: NLM
"Do We Know What We Are Adding?".

JACC. Cardiovascular interventions

Beckmann JH.
PMID: 27765316
JACC Cardiovasc Interv. 2016 Oct 24;9(20):2172. doi: 10.1016/j.jcin.2016.08.017.

No abstract available.

Cite
Beckmann JH. "Do We Know What We Are Adding?". JACC Cardiovasc Interv. 2016;9(20):2172doi: 10.1016/j.jcin.2016.08.017.
Beckmann, J. H. (2016). "Do We Know What We Are Adding?". JACC. Cardiovascular interventions, 9(20), 2172. https://doi.org/10.1016/j.jcin.2016.08.017
Beckmann, James H. ""Do We Know What We Are Adding?"." JACC. Cardiovascular interventions vol. 9,20 (2016): 2172. doi: https://doi.org/10.1016/j.jcin.2016.08.017
Beckmann JH. "Do We Know What We Are Adding?". JACC Cardiovasc Interv. 2016 Oct 24;9(20):2172. doi: 10.1016/j.jcin.2016.08.017. PMID: 27765316.
Copy Download .nbib Format: NLM
Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunities.

Genome medicine

Beckmann JS, Lew D.
PMID: 27993174
Genome Med. 2016 Dec 19;8(1):134. doi: 10.1186/s13073-016-0388-7.

This era of groundbreaking scientific developments in high-resolution, high-throughput technologies is allowing the cost-effective collection and analysis of huge, disparate datasets on individual health. Proper data mining and translation of the vast datasets into clinically actionable knowledge will require...

Cite
Beckmann JS, Lew D. Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunities. Genome Med. 2016;8(1):134doi: 10.1186/s13073-016-0388-7.
Beckmann, J. S., & Lew, D. (2016). Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunities. Genome medicine, 8(1), 134. https://doi.org/10.1186/s13073-016-0388-7
Beckmann, Jacques S, and Lew, Daniel. "Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunities." Genome medicine vol. 8,1 (2016): 134. doi: https://doi.org/10.1186/s13073-016-0388-7
Beckmann JS, Lew D. Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunities. Genome Med. 2016 Dec 19;8(1):134. doi: 10.1186/s13073-016-0388-7. PMID: 27993174; PMCID: PMC5165712.
Copy Download .nbib Format: NLM
Clinical validation of genetic variants associated with .

Oncotarget

Fasching PA, Häberle L, Rack B, Li L, Hein A, Ekici AB, Reis A, Lux MP, Cunningham JM, Ruebner M, Jenkins G, Fridley B, Schneeweiss A, Tesch H, Lichtenegger W, Fehm T, Heinrich G, Rezai M, Beckmann MW, Janni W, Weinshilboum RM, Wang L.
PMID: 29100455
Oncotarget. 2017 May 09;8(44):78133-78143. doi: 10.18632/oncotarget.17726. eCollection 2017 Sep 29.

Hematotoxicity is one of the major side effects of chemotherapy. The aim of this study was to examine the association between single nucleotide polymorphisms (SNPs) and hematotoxicity in breast cancer patients in a subset of patients of the SUCCESS...

Cite
Fasching PA, Häberle L, Rack B, et al. Clinical validation of genetic variants associated with . Oncotarget. 2017;8(44):78133-78143doi: 10.18632/oncotarget.17726.
Fasching, P. A., Häberle, L., Rack, B., Li, L., Hein, A., Ekici, A. B., Reis, A., Lux, M. P., Cunningham, J. M., Ruebner, M., Jenkins, G., Fridley, B., Schneeweiss, A., Tesch, H., Lichtenegger, W., Fehm, T., Heinrich, G., Rezai, M., Beckmann, M. W., Janni, W., Weinshilboum, R. M., & Wang, L. (2017). Clinical validation of genetic variants associated with . Oncotarget, 8(44), 78133-78143. https://doi.org/10.18632/oncotarget.17726
Fasching, Peter A, et al. "Clinical validation of genetic variants associated with ." Oncotarget vol. 8,44 (2017): 78133-78143. doi: https://doi.org/10.18632/oncotarget.17726
Fasching PA, Häberle L, Rack B, Li L, Hein A, Ekici AB, Reis A, Lux MP, Cunningham JM, Ruebner M, Jenkins G, Fridley B, Schneeweiss A, Tesch H, Lichtenegger W, Fehm T, Heinrich G, Rezai M, Beckmann MW, Janni W, Weinshilboum RM, Wang L. Clinical validation of genetic variants associated with . Oncotarget. 2017 May 09;8(44):78133-78143. doi: 10.18632/oncotarget.17726. eCollection 2017 Sep 29. PMID: 29100455; PMCID: PMC5652844.
Copy Download .nbib Format: NLM
Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention.

Geburtshilfe und Frauenheilkunde

Schneeweiss A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, Kolberg HC, Hadji P, Tesch H, Wöckel A, Ettl J, Lüftner D, Wallwiener M, Müller V, Beckmann MW, Belleville E, Wallwiener D, Brucker SY, Schütz F, Fasching PA, Fehm TN.
PMID: 29576630
Geburtshilfe Frauenheilkd. 2018 Mar;78(3):246-259. doi: 10.1055/s-0044-101614. Epub 2018 Mar 21.

The treatment of metastatic breast cancer has become more complicated due to increasing numbers of new therapies which need to be tested. Therapies are now being developed to treat special clinical or molecular subgroups. Even though intrinsic molecular subtypes...

Cite
Schneeweiss A, Lux MP, Janni W, et al. Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention. Geburtshilfe Frauenheilkd. 2018;78(3):246-259doi: 10.1055/s-0044-101614.
Schneeweiss, A., Lux, M. P., Janni, W., Hartkopf, A. D., Nabieva, N., Taran, F. A., Overkamp, F., Kolberg, H. C., Hadji, P., Tesch, H., Wöckel, A., Ettl, J., Lüftner, D., Wallwiener, M., Müller, V., Beckmann, M. W., Belleville, E., Wallwiener, D., Brucker, S. Y., Schütz, F., Fasching, P. A., & Fehm, T. N. (2018). Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention. Geburtshilfe und Frauenheilkunde, 78(3), 246-259. https://doi.org/10.1055/s-0044-101614
Schneeweiss, Andreas, et al. "Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention." Geburtshilfe und Frauenheilkunde vol. 78,3 (2018): 246-259. doi: https://doi.org/10.1055/s-0044-101614
Schneeweiss A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, Kolberg HC, Hadji P, Tesch H, Wöckel A, Ettl J, Lüftner D, Wallwiener M, Müller V, Beckmann MW, Belleville E, Wallwiener D, Brucker SY, Schütz F, Fasching PA, Fehm TN. Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention. Geburtshilfe Frauenheilkd. 2018 Mar;78(3):246-259. doi: 10.1055/s-0044-101614. Epub 2018 Mar 21. PMID: 29576630; PMCID: PMC5862553.
Copy Download .nbib Format: NLM
Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study.

Geburtshilfe und Frauenheilkunde

Fasching PA, Fehm T, Kellner S, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Würstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Fersis N, Kuhn T, Wolf C, Vollert HW, Breitbach GP, Janni W, Landthaler R, Kohls A, Rezek D, Noesslet T, Fischer G, Henschen S, Praetz T, Heyl V, Kühn T, Krauß T, Thomssen C, Kümmel S, Hohn A, Tesch H, Mundhenke C, Hein A, Rauh C, Bayer CM, Jacob A, Schmidt K, Belleville E, Hadji P, Wallwiener D, Grischke EM, Beckmann MW, Brucker SY.
PMID: 25568468
Geburtshilfe Frauenheilkd. 2014 Dec;74(12):1137-1143. doi: 10.1055/s-0034-1383401.

No abstract available.

Cite
Fasching PA, Fehm T, Kellner S, et al. Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study. Geburtshilfe Frauenheilkd. 2014;74(12):1137-1143doi: 10.1055/s-0034-1383401.
Fasching, P. A., Fehm, T., Kellner, S., de Waal, J., Rezai, M., Baier, B., Baake, G., Kolberg, H. C., Guggenberger, M., Warm, M., Harbeck, N., Würstlein, R., Deuker, J. U., Dall, P., Richter, B., Wachsmann, G., Brucker, C., Siebers, J. W., Fersis, N., Kuhn, T., Wolf, C., Vollert, H. W., Breitbach, G. P., Janni, W., Landthaler, R., Kohls, A., Rezek, D., Noesslet, T., Fischer, G., Henschen, S., Praetz, T., Heyl, V., Kühn, T., Krauß, T., Thomssen, C., Kümmel, S., Hohn, A., Tesch, H., Mundhenke, C., Hein, A., Rauh, C., Bayer, C. M., Jacob, A., Schmidt, K., Belleville, E., Hadji, P., Wallwiener, D., Grischke, E. M., Beckmann, M. W., & Brucker, S. Y. (2014). Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study. Geburtshilfe und Frauenheilkunde, 74(12), 1137-1143. https://doi.org/10.1055/s-0034-1383401
Fasching, P A, et al. "Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study." Geburtshilfe und Frauenheilkunde vol. 74,12 (2014): 1137-1143. doi: https://doi.org/10.1055/s-0034-1383401
Fasching PA, Fehm T, Kellner S, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Würstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Fersis N, Kuhn T, Wolf C, Vollert HW, Breitbach GP, Janni W, Landthaler R, Kohls A, Rezek D, Noesslet T, Fischer G, Henschen S, Praetz T, Heyl V, Kühn T, Krauß T, Thomssen C, Kümmel S, Hohn A, Tesch H, Mundhenke C, Hein A, Rauh C, Bayer CM, Jacob A, Schmidt K, Belleville E, Hadji P, Wallwiener D, Grischke EM, Beckmann MW, Brucker SY. Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study. Geburtshilfe Frauenheilkd. 2014 Dec;74(12):1137-1143. doi: 10.1055/s-0034-1383401. PMID: 25568468; PMCID: PMC4275317.
Copy Download .nbib Format: NLM
Restriction fragment length polymorphisms in genetic improvement: methodologies, mapping and costs.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik

Beckmann JS, Soller M.
PMID: 24258478
Theor Appl Genet. 1983 Nov;67(1):35-43. doi: 10.1007/BF00303919.

Recently a new class of genetic polymorphism, restriction fragment length polymorphisms (RFLPs), has been uncovered by the use of restriction endonucleases which cleave DNA molecules at specific sites and cloned DNA probes which detect specific homologous DNA fragments. RFLPs...

Cite
Beckmann JS, Soller M. Restriction fragment length polymorphisms in genetic improvement: methodologies, mapping and costs. Theor Appl Genet. 1983;67(1):35-43doi: 10.1007/BF00303919.
Beckmann, J. S., & Soller, M. (1983). Restriction fragment length polymorphisms in genetic improvement: methodologies, mapping and costs. TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik, 67(1), 35-43. https://doi.org/10.1007/BF00303919
Beckmann, J S, and Soller, M. "Restriction fragment length polymorphisms in genetic improvement: methodologies, mapping and costs." TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik vol. 67,1 (1983): 35-43. doi: https://doi.org/10.1007/BF00303919
Beckmann JS, Soller M. Restriction fragment length polymorphisms in genetic improvement: methodologies, mapping and costs. Theor Appl Genet. 1983 Nov;67(1):35-43. doi: 10.1007/BF00303919. PMID: 24258478.
Copy Download .nbib Format: NLM
Elevated amounts of methotrexate-binding protein, different from normal dihydrofolate reductase, in a petunia MTX(R)-cell line.

Plant molecular biology

Barg R, Perl M, Beckmann JS.
PMID: 24302527
Plant Mol Biol. 1987 Jan;8(1):87-94. doi: 10.1007/BF00016437.

A petunia cell line, 1ECB, was previously isolated by the stepwise selection procedure, for resistance to methotrexate (MTX), an antimetabolite for the enzyme dihydrofolate reductase (DHFR). Using ammonium sulfate precipitates of cell lysates of cell line 1ECB and its...

Cite
Barg R, Perl M, Beckmann JS. Elevated amounts of methotrexate-binding protein, different from normal dihydrofolate reductase, in a petunia MTX(R)-cell line. Plant Mol Biol. 1987;8(1):87-94doi: 10.1007/BF00016437.
Barg, R., Perl, M., & Beckmann, J. S. (1987). Elevated amounts of methotrexate-binding protein, different from normal dihydrofolate reductase, in a petunia MTX(R)-cell line. Plant molecular biology, 8(1), 87-94. https://doi.org/10.1007/BF00016437
Barg, R, et al. "Elevated amounts of methotrexate-binding protein, different from normal dihydrofolate reductase, in a petunia MTX(R)-cell line." Plant molecular biology vol. 8,1 (1987): 87-94. doi: https://doi.org/10.1007/BF00016437
Barg R, Perl M, Beckmann JS. Elevated amounts of methotrexate-binding protein, different from normal dihydrofolate reductase, in a petunia MTX(R)-cell line. Plant Mol Biol. 1987 Jan;8(1):87-94. doi: 10.1007/BF00016437. PMID: 24302527.
Copy Download .nbib Format: NLM
Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-Se.

Geburtshilfe und Frauenheilkunde

Schulz-Wendtland R, Bani M, Lux MP, Schwab S, Loehberg CR, Jud SM, Rauh C, Bayer CM, Beckmann MW, Uder M, Fasching PA, Adamietz B, Meier-Meitinger M.
PMID: 25298545
Geburtshilfe Frauenheilkd. 2012 May;72(5):408-411. doi: 10.1055/s-0031-1298158.

No abstract available.

Cite
Schulz-Wendtland R, Bani M, Lux MP, et al. Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-Se. Geburtshilfe Frauenheilkd. 2012;72(5):408-411doi: 10.1055/s-0031-1298158.
Schulz-Wendtland, R., Bani, M., Lux, M. P., Schwab, S., Loehberg, C. R., Jud, S. M., Rauh, C., Bayer, C. M., Beckmann, M. W., Uder, M., Fasching, P. A., Adamietz, B., & Meier-Meitinger, M. (2012). Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-Se. Geburtshilfe und Frauenheilkunde, 72(5), 408-411. https://doi.org/10.1055/s-0031-1298158
Schulz-Wendtland, R, et al. "Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-Se." Geburtshilfe und Frauenheilkunde vol. 72,5 (2012): 408-411. doi: https://doi.org/10.1055/s-0031-1298158
Schulz-Wendtland R, Bani M, Lux MP, Schwab S, Loehberg CR, Jud SM, Rauh C, Bayer CM, Beckmann MW, Uder M, Fasching PA, Adamietz B, Meier-Meitinger M. Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-Se. Geburtshilfe Frauenheilkd. 2012 May;72(5):408-411. doi: 10.1055/s-0031-1298158. PMID: 25298545; PMCID: PMC4168403.
Copy Download .nbib Format: NLM
Photoacoustic clutter reduction by inversion of a linear scatter model using plane wave ultrasound measurements.

Biomedical optics express

Schwab HM, Beckmann MF, Schmitz G.
PMID: 27446669
Biomed Opt Express. 2016 Mar 24;7(4):1468-78. doi: 10.1364/BOE.7.001468. eCollection 2016 Apr 01.

Photoacoustic imaging aims to visualize light absorption properties of biological tissue by receiving a sound wave that is generated inside the observed object as a result of the photoacoustic effect. In clinical applications, the strong light absorption in human...

Cite
Schwab HM, Beckmann MF, Schmitz G. Photoacoustic clutter reduction by inversion of a linear scatter model using plane wave ultrasound measurements. Biomed Opt Express. 2016;7(4):1468-78doi: 10.1364/BOE.7.001468.
Schwab, H. M., Beckmann, M. F., & Schmitz, G. (2016). Photoacoustic clutter reduction by inversion of a linear scatter model using plane wave ultrasound measurements. Biomedical optics express, 7(4), 1468-78. https://doi.org/10.1364/BOE.7.001468
Schwab, Hans-Martin, et al. "Photoacoustic clutter reduction by inversion of a linear scatter model using plane wave ultrasound measurements." Biomedical optics express vol. 7,4 (2016): 1468-78. doi: https://doi.org/10.1364/BOE.7.001468
Schwab HM, Beckmann MF, Schmitz G. Photoacoustic clutter reduction by inversion of a linear scatter model using plane wave ultrasound measurements. Biomed Opt Express. 2016 Mar 24;7(4):1468-78. doi: 10.1364/BOE.7.001468. eCollection 2016 Apr 01. PMID: 27446669; PMCID: PMC4929655.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 367 entries